CCL4 and CXCL8 were upregulated in NASH, CXCL2 was upregulated in HCV, and LGALS3, XCL2, and IL32 were overexpressed in PSC. This evidence concerns the gene XCL2 and metabolic dysfunction-associated steatohepatitis.